Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Science Signaling - Call For Papers

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 2 May 2008:
Vol. 320. no. 5876, pp. 667 - 670
DOI: 10.1126/science.1156037

Reports

Phosphorylation by p38 MAPK as an Alternative Pathway for GSK3β Inactivation

Tina M. Thornton,1 Gustavo Pedraza-Alva,1* Bin Deng,2,3 C. David Wood,1 Alexander Aronshtam,1 James L. Clements,4 Guadalupe Sabio,5 Roger J. Davis,5 Dwight E. Matthews,1,3 Bradley Doble,6 Mercedes Rincon1{dagger}

Glycogen synthase kinase 3β (GSK3β) is involved in metabolism, neurodegeneration, and cancer. Inhibition of GSK3β activity is the primary mechanism that regulates this widely expressed active kinase. Although the protein kinase Akt inhibits GSK3β by phosphorylation at the N terminus, preventing Akt-mediated phosphorylation does not affect the cell-survival pathway activated through the GSK3β substrate β-catenin. Here, we show that p38 mitogen-activated protein kinase (MAPK) also inactivates GSK3β by direct phosphorylation at its C terminus, and this inactivation can lead to an accumulation of β-catenin. p38 MAPK–mediated phosphorylation of GSK3β occurs primarily in the brain and thymocytes. Activation of β-catenin–mediated signaling through GSK3β inhibition provides a potential mechanism for p38 MAPK–mediated survival in specific tissues.

1 Department of Medicine/Immunobiology Program, University of Vermont, Burlington, VT 05405–0068, USA.
2 Department of Biology, University of Vermont, Burlington, VT 05405–0068, USA.
3 Department of Chemistry, University of Vermont, Burlington, VT 05405–0068, USA.
4 Department of Immunology, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
5 Program in Molecular Medicine, University of Massachusetts, Worcester, MA 01605, USA.
6 McMaster Stem Cell and Cancer Research Institute, McMaster University, Hamilton, Ontario, L8N 3Z5, Canada.

* Present address: Departamento de Medicina Molecular y Bioprocesos, Instituto de Biotecnología, Universidad Nacional Autónoma de México, Cuernavaca, 62210, México.

{dagger} To whom correspondence should be addressed. E-mail: mrincon{at}uvm.edu

Read the Full Text






ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)